New figures for England show 346,217 new cancer cases were diagnosed in 2022 – an average of 948 every day – compared to ...

In metastatic hormone-sensitive prostate cancer (mHSPC), adding the radioligand 177 Lu-PSMA-617 (Pluvicto) to androgen ...

Black men with advanced prostate cancer have a greater chance of survival after immunotherapy treatment, at least in part, because of ancestral gene variants in immune responses.

A ground-breaking study, conducted by researchers from the University of Virginia, Mount Sinai, the University of Michigan, ...

Patients with metastatic prostate cancer may have improved survival outcomes after undergoing next-generation PSMA PET ...

As part of the CURE® Educated Patient® Prostate Cancer Summit, an expert discussed the role genetic testing plays in ...

Prostate cancer is one of the most prevalent cancers among men, with the American Cancer Society estimating that ...

Under the new grant, Agarwal’s lab will work to not only confirm they have identified the correct compounds but to translate ...

Men with localized prostate cancer were randomly assigned to receive either SBRT or control radiotherapy in a phase 3 trial.

Researchers have identified the genetic risk factors that contribute to prostate cancer in a diverse group of African men.

Prostate cancer starts when cells in the prostate gland grow out of control. Those cells can spread to other parts of the body and affect healthy tissue. This can happen for several reasons.

There is a limit of eight, 30-minute appointments. To schedule an appointment, or inquire further, call the hospital’s social ...